Bladder cancer patients may avoid surgery with new drug combo
Disease control
Recruiting now
This phase 2 trial is testing whether two chemotherapy drugs, gemcitabine and docetaxel, given directly into the bladder can treat high-risk bladder cancer that did not respond to standard BCG therapy. About 174 adults will receive weekly treatments for 6 weeks, then monthly for …
Phase: PHASE2 • Sponsor: Michael A. O'Donnell • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC